Nanobiotix Receives Approval from ANSM to Start New Clinical Trial with NBTXR3

News   Jun 13, 2013

 
Nanobiotix Receives Approval from ANSM to Start New Clinical Trial with NBTXR3
 
 
FURTHER INFORMATION
 
 
 
 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE